Linda Heskamp1
1Newcastle University, United Kingdom
Synopsis
This lecture introduces the basic
principles of MR Spectroscopy at a basic level suitable for clinicians with a
specific focus on skeletal muscle. Metabolites detectable with 1H MRS,
31P MRS, 13C MRS and 23NA MRS will be
discussed together with the software and hardware requirements.
Magnetic resonance spectroscopy (MRS) is a non-invasive
technique that is able to measure the concentrations of different chemical
components in tissue; it can be used to measure tissue metabolism.
An MR spectrum shows peaks at different frequencies, because each
metabolite has a slightly different resonance frequency. This difference in resonance
frequency is the result of the electron shielding effect. Electrons rotate
around the nucleus and produce their own small local magnetic field (Bind)
in the presence of the main magnetic field (B0). The effective magnetic
field (Beffective) experienced by the nucleus is B0 minus
Bind. The electron shielding effect depends on the molecular structure
of a metabolite and therefore each metabolite experiences a slightly different Beffective.
The resonance frequency of metabolite is then determined by the Larmor equation
($$$\omega_{0}=\gamma B_{effective}$$$).
The resonance frequency and shielding effect are field dependent, which
makes it difficult to compare spectra between different field strength. This
issue is overcome by using the chemical shift instead of the resonance
frequency. Chemical shift is the difference in resonance frequency of a
metabolite relative to a reference compound and expressed in parts per million.
For 1H MRS, the chosen reference compound tetramethylsilane (TMS)
and consequently water will always resonate at 4.7 ppm, independent of field
strength.
This lecture will also discuss the following factors that affect the size
and shape of peak in the MR spectrum:
1) Concentration
of a nucleus in the measured sample determines the height of the peak
2) T1
and T2 relaxation times of the metabolite in combination with the chosen
repetition time (TR) and echo time (TE). The TR and TE affect the height of the
peak via the T1 and T2 relaxation times of the metabolite. Furthermore, the T2
relaxation time also affects the linewidth of a peak, longer T2 relaxation times
give narrower peaks.
3) Magnetic
inhomogeneity will reduce the T2* and lead to a broadening of the peaks in a
spectrum. To minimize this effect shimming is critical.
4) Presence
of hidden/underlying peaks can alter the shape of a peak.
5) Processed
like J-coupling can make the peak appear as multiplet instead of a singlet.
Further focus of this lecture will be on an overview of the detectable metabolites per
nucleus (1H, 31P, 13C and 23NA).This
will include the recently published consensus papers on how to reliably
measure metabolites detectable with 1H MRS and 31P MRS. Metabolites
to be discussed will for example be intramyocellular lipids, carnosine,
acetylcarnitine, phosphocreatine, inorganic phosphate and ATP.Acknowledgements
No acknowledgement found.References
Krssak et al. Proton magnetic resonance spectroscopy in skeletal muscle:Experts' consensus recommendations. NMR Biomed 2019. DOI: 10.1002/nbm.4266
Meyerspeer et al. 31P magnetic resonance spectroscopy in skeletal muscle:Experts' consensus recommendations. NMR Biomed 2019 DOI: 10.1002/nbm.4246
Popadic et al. Intramyocellular lipids and their dynamics assessed by 1Hmagnetic resonance spectroscopy. Clin Physiol Func Imaging 2017. doi: 10.1111/cpf.12346558
Valkovic et al. Multinuclear Magnetic Resonance Spectroscopy of Human Skeletal Muscle Metabolism in Training and Disease. http://dx.doi.org/10.5772/intechopen.77107
Kreis et al. Terminology and concepts for the characterization of in vivoMR spectroscopy methods and MR spectra: Background andexperts' consensus recommendations. NMR Biomed 2020. DOI: 10.1002/nbm.4347